Author: Hughes Marino
-
7 Best Commercial Lease Buyout Options for Companies in 2026
on

A cooler, more predictable capital market is reshaping how companies take control of their real estate in 2026. With commercial real estate interest rates stabilizing near 6%–6.5% for industrial and 6.5%–7.25% for office property, and a looming $1.8 trillion maturity wall creating motivated sellers and creative capital, buyers have more choice—and leverage—than they’ve had in
-

Commercial lease negotiations can make or break your business’s financial health. Without proper expertise, tenants often fall victim to hidden fees, unfavorable terms and costly oversights that drain resources for years. The average commercial lease contains dozens of complex clauses that can trigger unexpected expenses, from uncapped rent escalations to ambiguous maintenance responsibilities. By partnering
-

Breaking a commercial lease represents one of the most complex strategic decisions facing businesses today, particularly as 2025 had brought significant legislative changes emphasizing enhanced tenant rights across multiple jurisdictions. Unlike residential leases, commercial lease termination involves intricate legal, financial and operational considerations that can dramatically impact your company’s bottom line and future growth prospects.
-

Understanding Commercial Subleasing Commercial subleasing is when a tenant (primary tenant aka sublandlord or sublessor) leases all or part of their leased space to another party (subtenant or sublessee), creating a sublease agreement while maintaining responsibility for the original lease. In this arrangement, the primary tenant remains liable to the landlord under the original lease,
-

Click here to download our WOW Cards for your own team! Our team makes it a top priority to embrace recognition in the workplace, and to ensure that our team members are regularly recognized for creating “WOW-worthy” moments for our clients and for each other. At the beginning of each year, every teammate is provided
-

While the Covid pandemic feels like a distant memory, its aftereffects still reverberate through the business community. While there are headlines around the country regarding a shift of power back to the employer, and pressure by some companies to get people back in the office full-time, the reality is that many companies have become comfortable
-

Though Covid has become a distant memory, the aftershocks on the industrial real estate sector throughout the United States are going to be felt for years. The historic surge in warehouse demand from 2020 to 2022 has now been met with a grossly overbuilt speculative market, and a simultaneous contraction of industrial tenant requirements. As
-

In the last 14 years, we’ve proven that a strong, intentional culture isn’t fluff—it’s fuel. It’s what enables teams to go further, execute faster and deliver under pressure. And in a business environment that’s constantly shifting, culture might be your most underleveraged asset. Executives spend time optimizing strategy, capital and operations, but often overlook the
-

At Hughes Marino, our award-winning culture and team performance thrives on continuous improvement, knowing that EVERY detail matters. This includes identifying things, both big and small, that may not be running as smoothly as they could be and having the courage to speak up when challenges might arise. As part two of our HM-ism series, we wanted to focus on…
-

If you are a business owner or executive team member operating an industrial distribution or manufacturing company in the Inland Empire, you’re probably still picking off the scar tissue from the run-up of industrial rents from 2020 through 2022. The outbreak of Covid in second quarter of 2020 created a run on industrial real estate in the fall of 2020.…
-

From 2020-2022, the biotech industry was the standout of the U.S. capital markets, thanks to the vital role the industry played in the Covid-19 pandemic response and the unprecedented capital investment that flowed into the industry for the diagnosis and treatment of all disease conditions. With that fresh capital, biotech companies leased millions of square feet of biotech wet lab…
